Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?

Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?

<h3>Background</h3><p dir="ltr">The SARS-CoV-2 coronavirus gains entry to target cells via the angiotensin-converting enzyme 2 (ACE2) receptor present on cells in blood vessels, lungs, heart, intestines, and kidneys. Renin-Angiotensin System (RAS) overactivity has also be...

Full description

Saved in:

Bibliographic Details
Main Author:	Abu Saleh Md Moin (6189512) (author)
Other Authors:	Thozhukat Sathyapalan (704787) (author), Stephen L. Atkin (6684368) (author), Alexandra E. Butler (6189536) (author)
Published:	2020
Subjects:	Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Reproductive medicine ACE2 protein Polycystic ovary syndrome Renin Angiotensinogen
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
by: Abu Saleh Md Moin (6189512)
Published: (2021)

The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021)

Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?
by: Abu Saleh Md Moin (6189512)
Published: (2021)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2020)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
by: Alison J. Dawson (18175003)
Published: (2019)

The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
by: Moaz O. Moursi (17019030)
Published: (2023)

Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome
by: Richard J. Kirk (18174919)
Published: (2019)

Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
by: Ilhame Diboun (3522413)
Published: (2021)

Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
by: Robin Augustine (3976964)
Published: (2022)

Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
by: Abu Saleh Md Moin (6189512)
Published: (2021)

Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population
by: Santosh Kumar Sidhwani (16319194)
Published: (2023)

Hyponatremia and SARS-CoV-2 infection: A narrative review
by: Elmukhtar Habas (14777677)
Published: (2022)

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
by: Ishita Gupta (9203073)
Published: (2020)

The Effect of Genetic Polymorphism on Therapeutic Response of Metformin in Women with Polycystic Ovarian Syndrome in Iraqi Population
by: Al Shaikhly, Raya
Published: (2021)

Role of microRNA 690 in Mediating Angiotensin II Effects on Inflammation and Endoplasmic Reticulum Stress
by: Kalhara R. Menikdiwela (18566698)
Published: (2020)

Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
by: Alexandra E. Butler (6189536)
Published: (2020)

Clinical Phenotypes of PCOS: a Cross-Sectional Study
by: Abdalla Moustafa Elsayed (17807330)
Published: (2023)

Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study
by: Alexandra E. Butler (6189536)
Published: (2020)

Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs
by: Mohamed A. Elrayess (21398687)
Published: (2022)

In-vitro and in-silico evaluation of rue herb for SARS-CoV-2 treatment
by: Maliha Khandoker Minu (22224733)
Published: (2024)

Renin–angiotensin-system gene polymorphisms and depression
by: Saab, Yolande B.
Published: (2007)

Expression of microRNA in follicular fluid in women with and without PCOS
by: Alexandra E. Butler (6189536)
Published: (2019)

Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
by: Wesam S. Ahmed (10170053)
Published: (2022)

microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
by: Alexandra E. Butler (6189536)
Published: (2020)

Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex
by: Wesam S. Ahmed (10170053)
Published: (2022)

Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
by: Alexandra E. Butler (6189536)
Published: (2020)

The association of hypertension with renin–angiotensin system gene polymorphisms in the Lebanese population
by: Saab, YB
Published: (2011)

SARS‐CoV‐2 and guttate psoriasis: A case report and review of literature
by: Elrazi Ali (14777284)
Published: (2023)

Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
by: Noora Al-Hail (18140287)
Published: (2019)

Acute abdomen -like-presentation associated with SARS-CoV-2 infection
by: Ashraf Omer Elamin Ahmed (17115730)
Published: (2020)

Vocal Changes in Patients With Polycystic Ovary Syndrome
by: Hannoun, Antoine
Published: (2011)

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
by: Maria K. Smatti (4675852)
Published: (2022)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
by: Alena Liskova (11008851)
Published: (2021)

Fetoplacental transmission and placental response to SARS-CoV-2: Evidence from the literature
by: Henry C. Ezechukwu (13253406)
Published: (2022)

Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
by: Hussam Al Soub (17269024)
Published: (2021)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas (17337925)
Published: (2024)

SARS‐CoV‐2 omicron variant may present with severe sickle cell painful crisis: A report of two cases
by: Elrazi Ali (14777284)
Published: (2023)